Skip to main content
Erschienen in: Infection 1/2013

01.02.2013 | Case Report

Splenic marginal zone lymphoma in a HIV-1 infected patient: evidence favouring a pathogenetic role of HIV-1 itself in the lymphomagenesis

verfasst von: M. Cagliuso, V. Conti, S. Trasarti, L. Lombardi, M. Riminucci, M. Perez, O. Turriziani, F. Falasca, M. Nanni, A. Tafuri, I. Mezzaroma

Erschienen in: Infection | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

A rare case of splenic marginal zone lymphoma (SMZL) in a human immunodeficiency virus (HIV)-1 infected patient is described. As an association between SMZL and viral infections has been reported, the presence of the hepatitis C virus and HIV-1 genomes was evaluated. Only HIV-1 DNA levels were detected in enriched splenic B lymphocytes, suggesting a HIV-1 involvement in lymphomagenesis.
Literatur
1.
Zurück zum Zitat Thiele J, Zirbes TK, Bertsch HP, Titius BR, Lorenzen J, Fischer R. AIDS-related bone marrow lesions–myelodysplastic features or predominant inflammatory-reactive changes (HIV-myelopathy)? A comparative morphometric study by immunohistochemistry with special emphasis on apoptosis and PCNA-labeling. Ann Cell Pathol. 1996;11:141–57. Thiele J, Zirbes TK, Bertsch HP, Titius BR, Lorenzen J, Fischer R. AIDS-related bone marrow lesions–myelodysplastic features or predominant inflammatory-reactive changes (HIV-myelopathy)? A comparative morphometric study by immunohistochemistry with special emphasis on apoptosis and PCNA-labeling. Ann Cell Pathol. 1996;11:141–57.
2.
Zurück zum Zitat Tripathi AK, Misra R, Kalra P, Gupta N, Ahmad R. Bone marrow abnormalities in HIV disease. J Assoc Physicians India. 2005;53:705.PubMed Tripathi AK, Misra R, Kalra P, Gupta N, Ahmad R. Bone marrow abnormalities in HIV disease. J Assoc Physicians India. 2005;53:705.PubMed
3.
Zurück zum Zitat Isaacson PG, Piris MA, Berger F, Swerdlow SH, Thieblemont C, Pittaluga S, Harris NL. Splenic B-cell marginal zone lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. World Health Organization classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. p. 185–7. Isaacson PG, Piris MA, Berger F, Swerdlow SH, Thieblemont C, Pittaluga S, Harris NL. Splenic B-cell marginal zone lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. World Health Organization classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. p. 185–7.
4.
Zurück zum Zitat Tanaka Y, Hanada K, Mizokami M, Yeo AE, Shih JW, Gojobori T, Alter HJ. A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci USA. 2002;99:15584–9.PubMedCrossRef Tanaka Y, Hanada K, Mizokami M, Yeo AE, Shih JW, Gojobori T, Alter HJ. A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci USA. 2002;99:15584–9.PubMedCrossRef
5.
Zurück zum Zitat Riva E, Pistello M, Narciso P, D’Offizi G, Isola P, Galati V, Turriziani O, Tozzi V, Vincenzi L, Dianzani F, Antonelli G. Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapy. AIDS Res Hum Retrovir. 2001;17:1599–603.PubMedCrossRef Riva E, Pistello M, Narciso P, D’Offizi G, Isola P, Galati V, Turriziani O, Tozzi V, Vincenzi L, Dianzani F, Antonelli G. Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapy. AIDS Res Hum Retrovir. 2001;17:1599–603.PubMedCrossRef
6.
7.
Zurück zum Zitat Levine A, Sadeghi S, Espina B, Tulpule A, Nathwani B. Characteristics of indolent non-Hodgkin’s lymphoma in patients with type 1 human immunodeficiency virus infection. Cancer. 2002;94:1500–6.PubMedCrossRef Levine A, Sadeghi S, Espina B, Tulpule A, Nathwani B. Characteristics of indolent non-Hodgkin’s lymphoma in patients with type 1 human immunodeficiency virus infection. Cancer. 2002;94:1500–6.PubMedCrossRef
8.
Zurück zum Zitat McClain KL, Leach CT, Jenson HB, Joshi VV, Pollock BH, Hutchison RE, Murphy SB. Molecular and virologic characteristics of lymphoid malignancies in children with AIDS. J Acquir Immune Defic Syndr. 2000;23:152–9.PubMed McClain KL, Leach CT, Jenson HB, Joshi VV, Pollock BH, Hutchison RE, Murphy SB. Molecular and virologic characteristics of lymphoid malignancies in children with AIDS. J Acquir Immune Defic Syndr. 2000;23:152–9.PubMed
9.
Zurück zum Zitat Traverse-Glehen A, Baseggio L, Salles G, Felman P, Berger F. Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification. Curr Opin Oncol. 2011;23:441–8.PubMedCrossRef Traverse-Glehen A, Baseggio L, Salles G, Felman P, Berger F. Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification. Curr Opin Oncol. 2011;23:441–8.PubMedCrossRef
10.
Zurück zum Zitat Arcaini L, Sacchi P, Jemos V, Lucioni M, Rumi E, Dionigi P, Paulli M. Splenic marginal zone B-cell lymphoma in a HIV-positive patient: a case report. Ann Hematol. 2009;88:379–1604.PubMedCrossRef Arcaini L, Sacchi P, Jemos V, Lucioni M, Rumi E, Dionigi P, Paulli M. Splenic marginal zone B-cell lymphoma in a HIV-positive patient: a case report. Ann Hematol. 2009;88:379–1604.PubMedCrossRef
11.
Zurück zum Zitat Withehead A, Noy A. Successful treatment of marginal zone lymphoma with splenectomy alone despite HIV infection. AIDS. 2007;21:1655–6.PubMedCrossRef Withehead A, Noy A. Successful treatment of marginal zone lymphoma with splenectomy alone despite HIV infection. AIDS. 2007;21:1655–6.PubMedCrossRef
12.
Zurück zum Zitat Kundu RK, Sangiorgi F, Wu LY, Pattengale PK, Hinton DR, Gill PS, Maxson R. Expression of the human immunodeficiency Virus-Tat gene in lymphoid tissues of transgenic mice is associated with B-cell lymphoma. Blood. 1999;94:275–82.PubMed Kundu RK, Sangiorgi F, Wu LY, Pattengale PK, Hinton DR, Gill PS, Maxson R. Expression of the human immunodeficiency Virus-Tat gene in lymphoid tissues of transgenic mice is associated with B-cell lymphoma. Blood. 1999;94:275–82.PubMed
13.
Zurück zum Zitat Giagulli C, Marsico S, Magiera AK, Bruno R, Caccuri F, Barone I, Fiorentini S, Andò S, Caruso A. Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells. PLoS ONE. 2011;6:e17831.PubMedCrossRef Giagulli C, Marsico S, Magiera AK, Bruno R, Caccuri F, Barone I, Fiorentini S, Andò S, Caruso A. Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells. PLoS ONE. 2011;6:e17831.PubMedCrossRef
Metadaten
Titel
Splenic marginal zone lymphoma in a HIV-1 infected patient: evidence favouring a pathogenetic role of HIV-1 itself in the lymphomagenesis
verfasst von
M. Cagliuso
V. Conti
S. Trasarti
L. Lombardi
M. Riminucci
M. Perez
O. Turriziani
F. Falasca
M. Nanni
A. Tafuri
I. Mezzaroma
Publikationsdatum
01.02.2013
Verlag
Springer-Verlag
Erschienen in
Infection / Ausgabe 1/2013
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-012-0344-4

Weitere Artikel der Ausgabe 1/2013

Infection 1/2013 Zur Ausgabe

Images in Infection

Spinal cord toxoplasmosis

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.